These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 25695488

  • 21. Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient.
    Helbling P, Kröger S, Haas W, Brusin S, Cirillo DM, Groenheit R, Guthmann JP, Soini H, Hendrickx D, van der Werf MJ.
    Clin Microbiol Infect; 2018 Aug; 24(8):918-919. PubMed ID: 29559390
    [No Abstract] [Full Text] [Related]

  • 22. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO, Nizovtseva NI, Glomozda PG, Panasik VP, Duginova TN, Kuznetsov AA.
    Probl Tuberk Bolezn Legk; 2005 Aug; (5):19-21. PubMed ID: 15988972
    [Abstract] [Full Text] [Related]

  • 23. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia.
    Kelly PM, Ardian M, Waramori G, Anstey NM, Syahrial H, Tjitra E, Bastian I, Maguire GP, Lumb R.
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255
    [Abstract] [Full Text] [Related]

  • 24. Adult tuberculosis in Israel and migration: trends and challenges between 1999 and 2010.
    Mor Z, Pinsker G, Cedar N, Lidji M, Grotto I.
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1613-8. PubMed ID: 23131258
    [Abstract] [Full Text] [Related]

  • 25. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
    Mor Z, Goldblatt D, Kaidar-Shwartz H, Cedar N, Rorman E, Chemtob D.
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
    [Abstract] [Full Text] [Related]

  • 26. [The prevalence and risk factors of drug-resistant tuberculosis among migratory population in Shanghai, China].
    Shen X, Shen M, Gui XH, Gao Q, Mei J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):407-10. PubMed ID: 17673008
    [Abstract] [Full Text] [Related]

  • 27. Treatment of multidrug-resistant tuberculosis in a high-prevalence region through a binational consortium.
    Laniado-Laborín R, Estrada-Guzman J, Perez H, Batiz-Armenta F, Alcantar-Schramm JM.
    Int J Tuberc Lung Dis; 2012 May; 16(5):610-1. PubMed ID: 22410353
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for drug resistant tuberculosis in southeast Turkey.
    Tanrikulu AC, Hosoglu S, Ozekinci T, Abakay A, Gurkan F.
    Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
    [Abstract] [Full Text] [Related]

  • 29. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB, Sepkowitz KA, Stoeckle M, Friedman CR, Hafner A, Riley LW.
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [Abstract] [Full Text] [Related]

  • 30. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 31. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS.
    Ann Afr Med; 2010 Sep; 9(1):15-9. PubMed ID: 20418644
    [Abstract] [Full Text] [Related]

  • 32. Measuring the prevalence of Mycobacterium tuberculosis resistance is not that easy: the interest and limits of a retrospective survey.
    Chaulet P.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1077. PubMed ID: 11769763
    [No Abstract] [Full Text] [Related]

  • 33. Prevalence of extensively drug-resistant tuberculosis.
    Khurana AK, Mohapatra PR.
    Eur Respir J; 2009 Sep; 34(3):780; author reply 780-1. PubMed ID: 19720817
    [No Abstract] [Full Text] [Related]

  • 34. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W.
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
    Magee MJ, Blumberg HM, Broz D, Furner SE, Samson L, Singh S, Hershow RC.
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
    [Abstract] [Full Text] [Related]

  • 36. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
    Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ.
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
    [Abstract] [Full Text] [Related]

  • 37. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M, Boulle A, Goemaere E, van Cutsem G.
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [Abstract] [Full Text] [Related]

  • 38. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S.
    Clin Infect Dis; 2010 Jan 01; 50(1):49-55. PubMed ID: 19947856
    [Abstract] [Full Text] [Related]

  • 39. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
    Gler MT, Guilatco RS, Guray CV, Tupasi TE.
    Int J Tuberc Lung Dis; 2012 Oct 01; 16(10):1326-30. PubMed ID: 22863522
    [Abstract] [Full Text] [Related]

  • 40. Multidrug-resistant tuberculosis: treatment is empirical, for want of robust trials.
    Prescrire Int; 2014 Oct 01; 23(153):245-6. PubMed ID: 25964976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.